Related Experiment Video

Updated: Jul 9, 2026

Generation and Purification of Human INO80 Chromatin Remodeling Complexes and Subcomplexes
08:44

Generation and Purification of Human INO80 Chromatin Remodeling Complexes and Subcomplexes

Published on: October 23, 2014

[Influence of iNOS silencing by RNA interference on proliferation activity of Tca8113 cell]

Lan Yang1, Wei-Liang Chen, Shu-Guang Zeng

  • 1Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Sun Yat-sen University, Guangzhou 510140, China.

Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology
|December 12, 2007
PubMed
Abstract

Insights

Downregulating inducible nitric oxide synthase (iNOS) expression in Tca8113 cells via RNA interference promotes apoptosis and inhibits cell proliferation. This suggests iNOS plays a key role in Tca8113 cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology

Context:

  • The study focuses on Tca8113 cells, a relevant model for investigating cellular processes.
  • Inducible nitric oxide synthase (iNOS) is implicated in various cellular functions, including proliferation and apoptosis.

Purpose:

  • To investigate the effects of iNOS modulation on apoptosis and proliferation in Tca8113 cells.
  • To determine the role of iNOS in the regulation of Tca8113 cell activity.

Summary:

  • Short hairpin RNA targeting iNOS was used to downregulate its expression in Tca8113 cells.
  • Immunohistochemistry, flow cytometry, and MTT assays were employed to assess iNOS expression, apoptosis rates, and cell proliferation, respectively.
  • Results showed significantly decreased iNOS expression, increased apoptosis, and reduced proliferation in cells with downregulated iNOS compared to controls.

Impact:

  • Downregulation of iNOS via RNA interference effectively promotes apoptosis in Tca8113 cells.
  • This modulation exhibits anti-proliferative effects on Tca8113 cells, highlighting iNOS as a potential therapeutic target.

More Related Videos

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...